相关实验视频

Updated: Sep 15, 2025

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

模拟亲和力成熟的范式转变,以引起广泛中和抗体

Fahsai Nakarin¹, Kayla G Sprenger²

¹Biomedical Engineering Graduate Program, University of Colorado Boulder, Boulder, CO, United States.

Frontiers in immunology

|July 16, 2025

概括

开发广泛中和抗体 (bnAbs) 对于对抗不断演变的病毒至关重要. 本综述提出了抗体亲和力成熟 (AM) 的新模型,该模型考虑了不仅仅是结合强度之外的多种因素,改进了疫苗策略.

科学领域:

免疫学免疫学免疫学
分子生物学分子生物学
疫苗学疫苗学疫苗学

背景情况:

广泛中和抗体 (bnAbs) 是对抗HIV,流感和SARS-CoV-2等快速演变的病原体的关键.
通过疫苗接种引起bnAbs是具有挑战性的,在生殖中心 (GCs) 中抗体亲和力成熟 (AM) 是一个关键过程.
传统模型将AM视为仅由高亲和度B细胞受体 (BCR) 选择驱动,可能限制多样性.

研究的目的:

重新评估AM的传统亲和关系选择模型.
提出一个新的范式,在AM中整合多因素过程.
推进开发针对可变病原体的有效疫苗的战略.

主要方法:

审查和重新评估现有的基于亲和关系的选择模型对AM.
整合关于GC宽容性和B细胞多样性的新兴证据.
结合了随机B细胞动态,抗原提取效率和狂热效应.
突出了超出单一亲和力决定因素的高级AM模拟.

主要成果:

新出现的证据表明,GCs是宽容的,允许各种B细胞亲缘关系持续存在.
一个新的范式整合了随机性,抗原结合动态和贪性.
先进的模拟提供了更现实的AM表示.

结论:

抗体亲和力成熟是一个多因素的过程,不仅仅是由亲和力驱动的.
对AM的修订理解对于设计针对复杂,可变抗原的有效疫苗至关重要.
这项工作为开发改进的疫苗策略提供了一个框架,以引起bnAbs.

关键词:

B细胞是B细胞的组成部分.亲缘关系成熟的成熟.广泛中和抗体的抗体.发芽中心的发芽中心.模拟模拟是指一个模拟模拟器.

更多相关视频

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Conformational Evaluation of HIV-1 Trimeric Envelope Glycoproteins Using a Cell-based ELISA Assay

Published on: September 14, 2014

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood

Published on: February 6, 2018

相关概念视频

Affinity and Avidity

Affinity and Avidity

B Cell Activation and Differentiation

B Cell Activation and Differentiation

The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...

Hybridoma Technology

Hybridoma Technology

Hybridoma technology is used for the large-scale production of monoclonal antibodies. Monoclonal antibodies bind to only a single antigenic determinant or epitope. Such antibodies are used in research, diagnostics, and disease therapy. The hybridoma technology established in 1975 by Georges Köhler and Cesar Milstein was awarded the Nobel Prize in Medicine in 1984 for revolutionizing research and therapy.
Hybridoma Selection
Commonly used fusion techniques — electroporation,...

Diversity of Antigen Receptors

Diversity of Antigen Receptors

Antigen receptors are essential components of the immune system crucial in defending the body against foreign invaders. These receptors are present on the surface of B and T cells, enabling them to recognize antigens and mount an appropriate immune response.
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...